These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10501744)

  • 1. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies?
    De Vriese AS; Vanholder RC; Pascual M; Lameire NH; Colardyn FA
    Intensive Care Med; 1999 Sep; 25(9):903-10. PubMed ID: 10501744
    [No Abstract]   [Full Text] [Related]  

  • 2. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense?
    Schetz M; Ferdinande P; Van den Berghe G; Verwaest C; Lauwers P
    Intensive Care Med; 1995 Feb; 21(2):169-76. PubMed ID: 7775699
    [No Abstract]   [Full Text] [Related]  

  • 3. Composition of polymer membranes for therapies of end-stage renal disease.
    Radovich JM
    Contrib Nephrol; 1995; 113():11-24. PubMed ID: 7712717
    [No Abstract]   [Full Text] [Related]  

  • 4. Influencing the inflammatory response of haemodialysis patients by cytokine elimination using large-pore membranes.
    Schindler R; Senf R; Frei U
    Nephrol Dial Transplant; 2002 Jan; 17(1):17-9. PubMed ID: 11773455
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug dosing adjustments during continuous renal replacement therapies.
    Golper TA; Marx MA
    Kidney Int Suppl; 1998 May; 66():S165-8. PubMed ID: 9573596
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune response and immunomodulation in blood purification].
    Nakamura M; Hirasawa H; Hirano T; Nitta M
    Nihon Rinsho; 2004 May; 62 Suppl 5():50-4. PubMed ID: 15197887
    [No Abstract]   [Full Text] [Related]  

  • 7. A Continuous Renal Replacement Therapy Protocol on the Updated Nikkiso Aquarius Platform Using Regional Citrate as First-Line Anticoagulation Significantly Improves Filter Life Span but the Position of the Vascular Access is Key.
    Kirwan CJ; Jackson L; Prowle JR
    Blood Purif; 2018; 45(1-3):129-130. PubMed ID: 29402829
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytokine removal with high cut-off membrane: review of literature.
    Villa G; Zaragoza JJ; Sharma A; Neri M; De Gaudio AR; Ronco C
    Blood Purif; 2014; 38(3-4):167-73. PubMed ID: 25471681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are the synergistic effects of high-volume haemofiltration and enhanced adsorption the missing key in sepsis modulation?
    Joannes-Boyau O; Honore PM; Boer W; Collin V
    Nephrol Dial Transplant; 2009 Feb; 24(2):354-7. PubMed ID: 19054800
    [No Abstract]   [Full Text] [Related]  

  • 10. High cut-off membranes in acute kidney injury and continuous renal replacement therapy.
    Ricci Z; Romagnoli S; Ronco C
    Int J Artif Organs; 2017 Nov; 40(12):657-664. PubMed ID: 29178124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-renal indications for continuous renal replacement therapy: current status in Japan.
    Oda S; Sadahiro T; Hirayama Y; Nakamura M; Watanabe E; Tateishi Y; Hirasawa H
    Contrib Nephrol; 2010; 166():47-53. PubMed ID: 20472991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovations in dialysis membranes for improved kidney replacement therapy.
    Geremia I; Stamatialis D
    Nat Rev Nephrol; 2020 Oct; 16(10):550-551. PubMed ID: 32322085
    [No Abstract]   [Full Text] [Related]  

  • 13. [Continuous renal replacement therapy in idiopathic interstitial pneumonia].
    Saito Y; Totani Y; Hayashi M; Sasaki F; Sakakibara H
    Nihon Rinsho; 2004 May; 62 Suppl 5():531-5. PubMed ID: 15197978
    [No Abstract]   [Full Text] [Related]  

  • 14. Physical and chemical characteristics of different polyethersulfone membranes.
    Brandt T; Wiese F
    Contrib Nephrol; 2003; (138):1-12. PubMed ID: 12463141
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal replacement therapy in acute kidney injury: an overview.
    Kanagasundaram NS
    Br J Hosp Med (Lond); 2007 Jun; 68(6):292-7. PubMed ID: 17639824
    [No Abstract]   [Full Text] [Related]  

  • 16. Continuous renal replacement therapies in sepsis: where are the data?
    De Vriese AS; Vanholder RC; De Sutter JH; Colardyn FA; Lameire NH
    Nephrol Dial Transplant; 1998 Jun; 13(6):1362-4. PubMed ID: 9641160
    [No Abstract]   [Full Text] [Related]  

  • 17. Modalities of continuous renal replacement therapy: technical and clinical considerations.
    Cerdá J; Ronco C
    Semin Dial; 2009; 22(2):114-22. PubMed ID: 19426413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Super high-flux' or 'high cut-off' hemofiltration and hemodialysis.
    Naka T; Haase M; Bellomo R
    Contrib Nephrol; 2010; 166():181-189. PubMed ID: 20473007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulation during continuous renal replacement therapy.
    Mehta RL
    ASAIO J; 1994; 40(4):931-5. PubMed ID: 7858328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long road to wearable blood-cleansing devices.
    Kooman JP; van der Sande FM; Leunissen KM
    Blood Purif; 2007; 25(4):377-82. PubMed ID: 17785967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.